Literature DB >> 33975687

Recent progress in gastric cancer prevention.

Jin Young Park1, Rolando Herrero2.   

Abstract

Gastric cancer remains a major challenge to public health on a global scale, causing the loss of 19 million disability-adjusted life years worldwide in 2017. The future burden will increase due to population growth and ageing. Considering its absolute burden and persisting disparities, in addition to the substantial prevalence of Helicobacter pylori infection worldwide that is treatable, gastric cancer is a logical target for urgent global action for prevention. In this review, we discuss recent progress in gastric cancer prevention and propose a concerted international effort to implement population-based H. pylori treatment programmes, as the best evidence-based strategy that is currently available for gastric cancer prevention, in the context of demonstration projects in selected populations, to be later scaled up. It is time for urgent action to reduce the important loss of life and productivity caused by this preventable malignancy.
Copyright © 2021 World Health Organization. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Demonstration projects; Gastric cancer; H. pylori eradication; Prevention

Mesh:

Year:  2021        PMID: 33975687     DOI: 10.1016/j.bpg.2021.101733

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  3 in total

1.  Identification of AKIRIN2 as a potential biomarker and correlation with immunotherapy in gastric adenocarcinoma by integrated bioinformatics analysis.

Authors:  Shaopeng Sun; Jiajia Chen; Chunyan Weng; Yifan Lu; Chang Cai; Bin Lv
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

2.  Chinese and Global Burdens of Gastrointestinal Cancers From 1990 to 2019.

Authors:  Wangcheng Xie; Tingsong Yang; Jieliang Zuo; Zhilong Ma; Weidi Yu; Zhengyu Hu; Zhenshun Song
Journal:  Front Public Health       Date:  2022-07-13

Review 3.  Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy.

Authors:  Umme Hani; Riyaz Ali M Osmani; Sabina Yasmin; B H Jaswanth Gowda; Hissana Ather; Mohammad Yousuf Ansari; Ayesha Siddiqua; Mohammed Ghazwani; Adel Al Fatease; Ali H Alamri; Mohamed Rahamathulla; M Yasmin Begum; Shadma Wahab
Journal:  Pharmaceutics       Date:  2022-07-29       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.